US Stock MarketDetailed Quotes

EYPT EyePoint Pharmaceuticals

Watchlist
  • 8.760
  • -0.090-1.02%
Close Dec 2 16:00 ET
  • 8.760
  • 0.0000.00%
Post 16:00 ET
597.88MMarket Cap-4402P/E (TTM)

EyePoint Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EyePoint Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.775M--
--2024/Q4-- / 10.494M--
--2024/Q310.524M / 10.358M--
--2024/Q29.477M / 10.635M--
--2024/Q111.684M / 9.135M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.775M--
--2024/Q4-- / 10.494M--
--2024/Q310.524M / 10.358M--
--2024/Q29.477M / 10.635M--
--2024/Q111.684M / 9.135M--

Unlock Free Earnings Estimates

EyePoint Pharmaceuticals Earnings Reports

  • EyePoint Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:08 ET

  • EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments

    Nov 7 07:08 ET

  • EyePoint Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:13 ET

  • EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Developments

    Aug 7 07:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data